Connection

ANDREA CRUZ to Xenograft Model Antitumor Assays

This is a "connection" page, showing publications ANDREA CRUZ has written about Xenograft Model Antitumor Assays.
Connection Strength

0.026
  1. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.